BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 31711453)

  • 21. Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.
    Han Y; Yang J; Liu P; He X; Zhang C; Zhou S; Zhou L; Qin Y; Song Y; Sun Y; Shi Y
    Oncologist; 2019 Nov; 24(11):e1251-e1261. PubMed ID: 30952824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Red blood cell distribution width as a simple negative prognostic factor in patients with diffuse large B-cell lymphoma: a retrospective study.
    Periša V; Zibar L; Sinčić-Petričević J; Knezović A; Periša I; Barbić J
    Croat Med J; 2015 Aug; 56(4):334-43. PubMed ID: 26321026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revisiting beta-2 microglobulin as a prognostic marker in diffuse large B-cell lymphoma.
    Jelicic J; Juul-Jensen K; Bukumiric Z; Runason Simonsen M; Roost Clausen M; Ludvigsen Al-Mashhadi A; Schou Pedersen R; Bjørn Poulsen C; Ortved Gang A; Brown P; El-Galaly TC; Larsen TS
    Cancer Med; 2024 Jun; 13(12):e7239. PubMed ID: 38888359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of the Ratio of Peripheral Hemoglobin-to-Red Cell Distribution width on the Prognosis of Patients with Diffuse Large B-cell Lymphoma].
    Dong XY; Tang GF; Chen W; Cao J; Cheng H; Li ZY; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):765-770. PubMed ID: 35680803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic nomogram for diffuse large B-cell lymphoma incorporating the International Prognostic Index with interim-positron emission tomography findings.
    Chow A; Phillips M; Siew T; Cull G; Augustson B; Ward M; Joske D
    Intern Med J; 2013 Aug; 43(8):932-9. PubMed ID: 23692386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Enhanced International Prognostic Index for Diffuse Large B-cell Lymphoma.
    Yang Y; Wang L; Ma Y; Han T; Huang M
    Am J Med Sci; 2017 May; 353(5):459-465. PubMed ID: 28502332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of Red Blood Cell Distribution Width and Fibrinogen Level for Evaluation of the Therapeutic Efficacy and Prognosis in Patients with Diffuse Large B-Cell Lymphoma].
    Wang X; Wu CY; Zeng PY; Li LL; Ma CC; Xiang X; Li YQ; Chai Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):153-159. PubMed ID: 32027269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Useful prognostic tools based on complete blood cell counts in diffuse large B-cell lymphoma.
    Shimono J; Takahashi S; Takemura R; Kakinoki Y
    Int J Lab Hematol; 2019 Dec; 41(6):754-761. PubMed ID: 31529774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Research of prognostic immunophenotypes in 163 patients of diffuse large B-cell lymphoma].
    Yang X; Chen S; Qi Y; Xu XY; Guan X; Yang YC; Liu YX; Guo YH; Gong WC; Gao YN; Wang XH; Li W; Li LF; Fu K; Zhang HL; Meng B
    Zhonghua Xue Ye Xue Za Zhi; 2021 Jun; 42(6):487-494. PubMed ID: 34384155
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor.
    Bairey O; Shacham-Abulafia A; Shpilberg O; Gurion R
    Hematol Oncol; 2016 Dec; 34(4):184-192. PubMed ID: 26052918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
    Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
    Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic significance of pretreatment red blood cell distribution width in primary diffuse large B-cell lymphoma of the central nervous system for 3P medical approaches in multiple cohorts.
    Li D; Li S; Xia Z; Cao J; Zhang J; Chen B; Zhang X; Zhu W; Fang J; Liu Q; Hua W
    EPMA J; 2022 Sep; 13(3):499-517. PubMed ID: 36061828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Role of Red Cell Distribution Width (RDW) in Patients with Diffuse Large B-cell Lymphoma.
    Kamandi N; Soleimanian A; Allahyari A; Kamandi M
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2667-2672. PubMed ID: 37642052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab.
    Oki Y; Yamamoto K; Kato H; Kuwatsuka Y; Taji H; Kagami Y; Morishima Y
    Eur J Haematol; 2008 Dec; 81(6):448-53. PubMed ID: 18691256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A promising prognostic model for predicting survival of patients with HIV-related diffuse large B-cell lymphoma in the cART era.
    Chen J; Wu Y; Kang Z; Qin S; Ruan G; Zhao H; Tao X; Xie Z; Peng J
    Cancer Med; 2023 Jun; 12(11):12470-12481. PubMed ID: 37081761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prognostic nomogram incorporating red cell distribution width for patients with intracerebral hemorrhage.
    Cui Z; Liu C; Sun G; Huang L; Zhou W
    Medicine (Baltimore); 2020 Dec; 99(50):e23557. PubMed ID: 33327308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma.
    Cox MC; Nofroni I; Ruco L; Amodeo R; Ferrari A; La Verde G; Cardelli P; Montefusco E; Conte E; Monarca B; Aloe-Spiriti MA
    Leuk Lymphoma; 2008 Sep; 49(9):1745-51. PubMed ID: 18798109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.
    Chen Y; Neelapu S; Feng L; Bi W; Yang TH; Wang M; Fanale MA; Westin JR; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Fowler NH; McLaughlin P; Cabanillas F; Oki Y; Nastoupil LJ; Rodriguez A
    Br J Haematol; 2016 Oct; 175(2):290-299. PubMed ID: 27448187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral Blood Lymphocyte-to-Monocyte Ratio at Relapse Predicts Outcome for Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in the Rituximab Era.
    Katoh D; Ochi Y; Yabushita T; Ono Y; Hiramoto N; Yoshioka S; Yonetani N; Matsushita A; Hashimoto H; Kaji S; Imai Y; Ishikawa T
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e91-e97. PubMed ID: 28918104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.